Sequence analysis of the DNA binding domain of the estrogen receptor gene in ER (+)/PR (-) breast cancer

Diagnostic Molecular Pathology

Volumn 5, Issue 1, 1996, Pages 39-44

  Mies, Carolyn ^a   Voigt, Walter ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen receptor; Progesterone receptor

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; SIGNAL PEPTIDE;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; DNA BINDING; DNA FLANKING REGION; DNA SEQUENCE; GENE AMPLIFICATION; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; HUMANS; PROTEIN BINDING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEQUENCE ANALYSIS, DNA;

EID: 0030027459     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199603000-00007     Document Type: Article

References (43)

1. Allard MW, Ellsworth DL, Honeycutt RL. The production of single-stranded DNA suitable for sequencing using the polymerase chain reaction. Biotechniques 1991;10:24-6.
2. Anselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, Postel-Vinay M, Goossens M. Laron dwarfism and mutations of the growth hormone receptor gene. N Engl J Med 1989;321:989-95.
3. Barrett-Lee PJ, Travers MT, McClelland RA, Luqmani Y, Coombes RC. Characterization of estrogen receptor messenger RNA in human breast cancer. Cancer Res 1987;47: 6653-9.
4. Beato M. Gene regulation by steroid hormones. Cell 1989; 56:335-44.
5. Castagnoli A, Maestri I, Bernardi F, Del Senno L. Pvull RFLP inside the human estrogen receptor gene. Nucleic Acids Res 1987;15:866.
6. Cheng J, Haas M. Sensitivity of detection of heterozygous point mutations in p53 cDNAs by direct PCR sequencing. PCR Methods Appl 1992;1:199-201.
7. Dotzlaw H, Alkhalaf M, Murphy LC. Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol 1992;6:773-85.
8. Dotzlaw H, Murphy LC. Cloning and sequencing of a variant sized estrogen receptor (ER) mRNA detected in some human breast cancer biopsies [Abstract]. Breast Cancer Res Treat 1990;16:147.
9. Erlich HA, Gelfand D, Sninsky JJ. Recent advances in the polymerase chain reaction. Science 1991;252:1643-51.
10. Fawell SE, Lees JA, White R, Parker MG. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 1990;60:953-62.
11. Fuqua SAW, Allred DC, Elledge RM, Krieg SL, Benedix MG, Nawaz Z, O'Malley BW, Greene GL, McGuire WL. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Res Treat 1993;26:191-202.
12. Fuqua SAW, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 1992; 52:483-6.
13. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 1991;51:105-9.
14. Garcia T, Lehrer S, Bloomer WD, Schachter B. A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mot Endocrinol 1988;2:785-91.
15. Garcia T, Sanchez M, Cox JL, Shaw PA, Ross JBA, Lehrer S, Schachter B. Identification of a variant form of the human estrogen receptor with an amino acid replacement. Nucleic Acids Res 1989;17:8364.
16. CO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance. Cancer Res 1990;50:6208-17.
17. Green S, Walter P, Kumar V, Krust A, Bornert J, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986;320: 134-9.
18. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986;231:1150-4.
19. Harlow KW, Smith DN, Katzenellenbogen JA, Greene GL, Katzenellenbogen BS. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor. J Biol Chem 1989;264: 17476-85.
20. Henry JA, Nicholson S, Farndon JR, Westley BR, May FEB. Measurement of oestrogen receptor mRNA levels in human breast tumours. Br J Cancer 1988;58:600-5.
21. Hill SM, Fuqua SA, Chamness GC, Greene GL, McGuire WL. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res 1989;49:145-8.
22. Horwitz KB, McGuire WL, Pearson OH, Segaloff A. Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 1975;189:726-7.
23. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, O'Malley B. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 1988;242:1702-5.
24. Jiang S-Y, Langan-Fahey SM, Stella AL, McCague R, Jordan VC. Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER. Mol Endocrinol 1992;6:2167-74.
25. Koh EH, Ro J, Wildrick DM, Hortobagyi GN, Blick M. Analysis of the estrogen receptor gene structure in human breast cancer. Anticancer Res 1989;184:1-6.
26. Kumar V, Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 1988;55:145-56.
27. Kumar V, Green S, Stack G, Berry M, Jin J-R, Chambon P. Functional domains of the human estrogen receptor. Cell 1987;51:941-51.
28. Lippman ME, Allegra JC. Receptors in breast cancer. N Engl J Med 1978;299:930-3.
29. Lippman ME, Huff KK, Jakesz R, Hecht T, Kasid A, Bates S, Dickson RB. Estrogens regulate production of specific growth factors in hormone-dependent human breast cancer. Ann NY Acad Sci 1986;464:11-6.
30. Lobaccaro J-M, Sumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Namer M, Cutuli BF, Pujol H, Sultan C. Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 1993;2:1799-802.
31. Mader S, Kumar V, deVerneuil H, Chambon P. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 1989;338:271-4.
32. McGuire WL, Chamness GC, Fuqua SA. Abnormal estrogen receptor in clinical breast cancer. J Steroid Biochem Mol Biol 1992;42:1-3.
33. McGuire WL, DeLa Garza M, Chamness GC. Evaluation of estrogen receptor assays in human breast cancer tissues. Cancer Res 1977;37:637-9.
34. McGuire WL, Horwitz KB, Pearson OH, Segaloff A. Current status of estrogen and progesterone receptors in breast cancer. Cancer 1977;39:2934-47.
35. Mies C, Voigt W, Davidow P. DNA sequence analysis of the DNA binding domain of the estrogen receptor gene in ER (+)/PR (-) breast carcinomas [Abstract]. Lab Invest 1993; 68:17A.
36. Murphy LC, Dotzlaw H. Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol Endocrinol 1989;3:687-93.
37. Murphy LC, Dotzlaw H, Hamerton J, Schwarz J. Investigation of the origin of variant, truncated estrogen receptor-like mRNAs identified in some human breast cancer biopsy samples. Breast Cancer Res Treat 1989;26:149-61.
38. Parl FF, Cavener DR, Dupont WD. Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res Treat 1989;14:57-64.
39. Pfeffer U, Fecarotta E, Castagnetta L, Vidali G. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-response human breast cancer cell lines. Cancer Res 1993; 53:741-3.
40. Ponglikitmongkol M, Green S, Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J 1988;7:3385-8.
41. Suzuki H, Sato N, Watabe Y, Motoyuki M, Seino S, Shimazaki J. Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 1993;46:759-65.
42. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 1989;59:477-87.
43. Witliff JL. Steroid hormone receptors in breast cancer. Cancer 1984;53:630-43.